<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Aspirantskiy Vestnik Povolzhiya</journal-id><journal-title-group><journal-title xml:lang="en">Aspirantskiy Vestnik Povolzhiya</journal-title><trans-title-group xml:lang="ru"><trans-title>Аспирантский вестник Поволжья</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2072-2354</issn><issn publication-format="electronic">2410-3764</issn><publisher><publisher-name xml:lang="en">Samara State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">627315</article-id><article-id pub-id-type="doi">10.35693/AVP627315</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>OTORHINOLARYNGOLOGY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОТОРИНОЛАРИНГОЛОГИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Clinical features of coronavirus infection with concurrent olfactory dysfunction</article-title><trans-title-group xml:lang="ru"><trans-title>Клинические особенности коронавирусной инфекции, протекающей с нарушением обоняния</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3614-886X</contrib-id><name-alternatives><name xml:lang="en"><surname>Lukyanov</surname><given-names>Aleksandr V.</given-names></name><name xml:lang="ru"><surname>Лукьянов</surname><given-names>Александр В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>a postgraduate student, assistant at the Department of Pediatrics with Infectious Diseases in Children</p></bio><bio xml:lang="ru"><p>аспирант, ассистент кафедры педиатрии с инфекционным болезнями у детей</p></bio><email>a.sheremetew@yandex.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3612-1889</contrib-id><name-alternatives><name xml:lang="en"><surname>Ploskireva</surname><given-names>Antonina A.</given-names></name><name xml:lang="ru"><surname>Плоскирева</surname><given-names>Антонина А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, Professor of the RAS, Deputy Director for Clinical Work</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор РАН, заместитель директора по клинической работе</p></bio><email>antoninna@mail.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Central Research Institute of Epidemiology of Rospotrebnadzor</institution></aff><aff><institution xml:lang="ru">ФБУН ЦНИИ эпидемиологии Роспотребнадзора</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Pirogov Russian National Research Medical University</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО РНИМУ имени Н.И. Пирогова Минздрава России</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2024-03-22" publication-format="electronic"><day>22</day><month>03</month><year>2024</year></pub-date><pub-date date-type="pub" iso-8601-date="2024-08-26" publication-format="electronic"><day>26</day><month>08</month><year>2024</year></pub-date><volume>24</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>15</fpage><lpage>19</lpage><history><date date-type="received" iso-8601-date="2024-02-21"><day>21</day><month>02</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-03-10"><day>10</day><month>03</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Lukyanov A.V., Ploskireva A.A.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Лукьянов А.В., Плоскирева А.А.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Lukyanov A.V., Ploskireva A.A.</copyright-holder><copyright-holder xml:lang="ru">Лукьянов А.В., Плоскирева А.А.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://aspvestnik.ru/2410-3764/article/view/627315">https://aspvestnik.ru/2410-3764/article/view/627315</self-uri><abstract xml:lang="en"><p><bold>Aim</bold> – to identify the clinical features of low-symptomatic forms of COVID-19 coronavirus infection with accompanying olfactory dysfunction.</p> <p><bold>Material and methods.</bold> The study included the survey of people with a history of coronavirus infection conducted on the basis of the Central Research Institute of Epidemiology of Rospotrebnadzor. A total of 39,676 patients were interviewed, of whom 24,086 (60.70%) had suffered some form of new coronavirus infection COVID-19. Methods of descriptive statistics were used for processing the research results.</p> <p><bold>Results.</bold> Olfactory dysfunction was the only symptom of the acute period of COVID-19 infection in 4% of patients. The occurrence of this symptom depended on the dominant circulating genovariant, with the maximum of 7.8% during Alpha, the basic reproduction number (inverse relationship, Pearson correlation coefficient -0.9) and the age of the patient (more often in persons under 44 years of age). The occurrence of the symptom had no correlation with the patient's gender. Patients with olfactory dysfunction during the COVID-19 infection were significantly less likely (4.2% vs. 12.6%, P = 0.04) to require hospitalization and oxygen therapy (2.5% vs. 32.2%, P &lt; 0.001).</p> <p><bold>Conclusion.</bold> Olfactory dysfunction may be the only symptom of the acute period of COVID-19 infection, which allows us to suggest its isolation into a separate form. The occurrence of this form depends on the dominant circulating genovariant, the basic reproductive number of the virus and the age of the patient. Patients with this form of coronavirus infection are less likely to require hospitalization and oxygen therapy.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Цель</bold> – выявление клинических особенностей малосимптомных форм коронавирусной инфекции COVID-19, протекающих с обонятельной дисфункцией.</p> <p><bold>Материал и методы.</bold> Исследование проводилось на базе ФБУН ЦНИИ эпидемиологии Роспотребнадзора методом анкетирования лиц, перенесших коронавирусную инфекцию. Всего было опрошено 39 676 человек, из которых 24 086 (60,70%) перенесли в той или иной форме новую коронавирусную инфекцию COVID-19. Для статистического анализа результатов исследования использовались методы описательной статистики.</p> <p><bold>Результаты. </bold>Обонятельная дисфункция может являться единственным симптомом острого периода коронавирусной инфекции COVID-19 в 4%. Встречаемость этого симптома зависит от доминирующего циркулирующего геноварианта (максимальная при альфа – 7,8%), базового репродуктивного числа (обратная зависимость, коэффициент корреляции Пирсона -0,9) и возраста пациента (чаще у лиц до 44 лет). Встречаемость симптома не зависит от пола пациента. Пациенты с обонятельной дисфункцией при коронавирусной инфекции COVID-19 достоверно реже (4,2% против 12,6%, P = 0.04) требуют госпитализации и оксигенотерапии (2,5% против 32,2%, P &lt; 0.001).</p> <p><bold>Заключение.</bold> Обонятельная дисфункция может быть единственным симптомом острого периода коронавирусной инфекции COVID-19, что позволяет предложить выделение ее в отдельную форму. Встречаемость такой формы зависит от доминирующего циркулирующего геноварианта, базового репродуктивного числа вируса и возраста пациента. Пациентам с такой формой коронавирусной инфекции реже требуется госпитализация и оксигенотерапия.</p></trans-abstract><kwd-group xml:lang="en"><kwd>COVID-19</kwd><kwd>olfactory dysfunction</kwd><kwd>olfactory impairment</kwd><kwd>parosmia</kwd><kwd>anosmia</kwd><kwd>phantosmia</kwd><kwd>hyposmia</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>COVID-19</kwd><kwd>обонятельная дисфункция</kwd><kwd>нарушение обоняния</kwd><kwd>паросмия</kwd><kwd>аносмия</kwd><kwd>фантосмия</kwd><kwd>гипосмия</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Lee Y, Min P, Lee S, Kim S.-W. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients. Journal of Korean Medical Science. 2020;35(18). https://doi.org/10.3346/jkms.2020.35.e174</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Klopfenstein T, et al. Features of anosmia in COVID-19. Médecine et Maladies Infectieuses. 2020;50(5):436-439. https://doi.org/10.1016/j.medmal.2020.04.006</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Lechien R, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. European Archives of Oto-Rhino-Laryngology. 2020;277(8):2251-2261. https://doi.org/10.1007/s00405-020-05965-1</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Vaira LA. Olfactory and gustatory function impairment in COVID-19 patients: An Italian objective multicenter-study. Authorea. 2020. https://doi.org/10.22541/au.158879175.53282134</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Yan Q, Qiu D, Liu X, et al. Prevalence of Smell or Taste Dysfunction Among Children With COVID-19 Infection: A Systematic Review and Meta-Analysis. Frontiers in Pediatrics. 2021;9. https://doi.org/10.3389/fped.2021.686600</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Voitenkov VB, Ekusheva EV, Bedova MA. Anosmia and ageusia in patients with COVID-19 infection. Folia Otorhinolaryngologiae et Pathologiae Respiratoriae. 2020;3:23-28. (In Russ.). [Войтенков В.Б., Екушева Е.В., Бедова М.А. Аносмия и агевзия у пациентов с инфекцией COVID-19. Folia Otorhinolaryngologiae et Pathologiae Respiratoriae. 2020;3:23-28].</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Sidorovich EA, Askerko MK, Vysotskaya MYu. Prevalence of olfactory and gustatory dysfunction in people who have had COVID-19 (based on survey results). Grodno, 2021:92-94. (In Russ.). [Сидорович Е.А., Аскерко М.К., Высоцкая М.Ю. Распространенность обонятельной и вкусовой дисфункции у лиц, перенесших COVID-19 (по результатам анкетирования). В сб.: Актуальные вопросы микробиологии, иммунологии и инфектологии. Гродно, 2021:92-94]. https://www.elibrary.ru/item.asp?id=47632254</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Hopkins C, Surda P, Kumar N. Presentation of New Onset Anosmia During the COVID-19 Pandemic. Rhinology Journal. 2020;58(3):295-298. https://doi.org/10.4193/rhin20.116</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Le Bon S.-D, Pisarski N, Verbeke J. Psychophysical evaluation of chemosensory functions 5 weeks after olfactory loss due to COVID-19: a prospective cohort study on 72 patients. European Archives of Oto-Rhino-Laryngology. 2020;278(1):101-108. https://doi.org/10.1007/s00405-020-06267-2</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Whitcroft KL, Hummel T. Olfactory Dysfunction in COVID-19. JAMA. 2020;323(24):2512. https://doi.org/10.1001/jama.2020.8391</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Hopkins C, et al. Management of new onset loss of sense of smell during the COVID-19 pandemic – BRS Consensus Guidelines. Clinical Otolaryngology. 2020;46(1):16-22. https://doi.org/10.1111/coa.13636</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Politi LS, Salsano E, Grimaldi M. Magnetic Resonance Imaging Alteration of the Brain in a Patient With Coronavirus Disease 2019 (COVID-19) and Anosmia. JAMA Neurology. 2020;77(8):1028. https://doi.org/10.1001/jamaneurol.2020.2125</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Heneka MT, Golenbock D, Latz E, et al. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimer’s Research &amp; Therapy. 2020;12(1):69. https://doi.org/10.1186/s13195-020-00640-3</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Russell B, Moss C, Rigg A, et al. Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say? Ecancermedicalscience. 2020;14:ed98. https://doi.org/10.3332/ecancer.2020.ed98</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Moein ST, Hashemian SM, Mansourafshar B, et al. Smell dysfunction: a biomarker for COVID-19. International Forum of Allergy Rhinology. 2020;10(8):944-950. https://doi.org/10.1002/alr.22587</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Brann DH, Tsukahara T, Weinreb C, et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Science Advances. 2020;6(31):eabc5801. https://doi.org/10.1126/sciadv.abc5801</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Munhoz RP, et al. Neurological complications in patients with SARS-CoV-2 infection: a systematic review. Arquivos de Neuro-Psiquiatria. 2020;78(5):290-300. https://doi.org/10.1590/0004-282x20200051</mixed-citation></ref></ref-list></back></article>
